Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
With Unapproved Drug Complete Response Letters Now Public, Are Action Packages Next?
Jan 12 2026
•
By
Sue Sutter
The public release of action packages for unapproved drugs would be more complex than releasing CRLs.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Complete Response Letters
More from United States